Danaher Corporation (DHR)
NYSE: DHR · Real-Time Price · USD
178.98
-1.64 (-0.91%)
At close: Apr 28, 2026, 4:00 PM EDT
179.05
+0.07 (0.04%)
After-hours: Apr 28, 2026, 7:56 PM EDT
Danaher Revenue
Danaher had revenue of $5.95B in the quarter ending March 27, 2026, with 3.66% growth. This brings the company's revenue in the last twelve months to $24.78B, up 4.02% year-over-year. In the year 2025, Danaher had annual revenue of $24.57B with 2.90% growth.
Revenue (ttm)
$24.78B
Revenue Growth
+4.02%
P/S Ratio
5.11
Revenue / Employee
$412,967
Employees
60,000
Market Cap
126.68B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 24.57B | 693.00M | 2.90% |
| Dec 31, 2024 | 23.88B | -15.00M | -0.06% |
| Dec 31, 2023 | 23.89B | -2.75B | -10.33% |
| Dec 31, 2022 | 26.64B | 1.84B | 7.42% |
| Dec 31, 2021 | 24.80B | 2.52B | 11.30% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Thermo Fisher Scientific | 45.20B |
| IQVIA Holdings | 16.31B |
| Labcorp Holdings | 13.95B |
| Quest Diagnostics | 11.28B |
| Agilent Technologies | 7.07B |
| Illumina | 4.34B |
| IDEXX Laboratories | 4.30B |
| Mettler-Toledo International | 4.03B |
DHR News
- 5 days ago - Danaher reaches $172.5 million settlement with shareholders over post-pandemic outlook - Reuters
- 6 days ago - Danaher Announces Pricing of Euro-Denominated Senior Notes Offering - PRNewsWire
- 7 days ago - Danaher Q1 Earnings Beat Estimates, But Revenue Miss, Weak Diagnostics Weigh On Stock - Benzinga
- 7 days ago - Danaher Earnings Call Transcript: Q1 2026 - Transcripts
- 7 days ago - Danaher Lifts Full-Year Forecast on Biotech, Life Sciences Gains - WSJ
- 7 days ago - Danaher beats first-quarter profit estimates on strong bioprocessing demand - Reuters
- 7 days ago - Danaher Reports First Quarter 2026 Results - PRNewsWire
- 15 days ago - Beckman Coulter Diagnostics Earns CE Mark for New Assay Delivering Bacterial vs. Viral Infection Results in Approximately 20 Minutes - PRNewsWire